Filtered By:
Source: Thrombosis and Haemostasis
Condition: Atrial Fibrillation

This page shows you your search results in order of relevance. This is page number 5.

Order by Relevance | Date

Total 186 results found since Jan 2013.

Early rhythm control and the risks of ischaemic stroke, heart failure, mortality and adverse events when performed early ( & lt;3 months)
CONCLUSIONS: Early rhythm control, especially when performed earlier (<3months), was associated with a lower risk of adverse events than usual care among patients with early AF.PMID:35322396 | DOI:10.1055/a-1807-0336
Source: Thrombosis and Haemostasis - March 24, 2022 Category: Hematology Authors: Tze-Fan Chao Yi-Hsin Chan Chern-En Chiang Ta-Chuan Tuan Jo-Nan Liao Tzeng-Ji Chen Gregory Yh Lip Shih-Ann Chen Source Type: research

Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation"
Abstract PMID: 23803875 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - June 27, 2013 Category: Hematology Authors: Stöllberger C, Finsterer J Tags: Thromb Haemost Source Type: research

Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: A case report.
PMID: 24136295 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - October 17, 2013 Category: Hematology Authors: Rohla M, Freynhofer MK, Hammerl H, Weiss TW, Huber K Tags: Thromb Haemost Source Type: research

Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
PMID: 25743201 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - March 6, 2015 Category: Hematology Authors: Olesen JB, Torp-Pedersen C Tags: Thromb Haemost Source Type: research

The risks of risk scores for stroke risk assessment in atrial fibrillation.
PMID: 25759209 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - March 11, 2015 Category: Hematology Authors: Nielsen PB, Chao TF Tags: Thromb Haemost Source Type: research

Dabigatran in 'real-world' clinical practice for stroke prevention in patients with non-valvular atrial fibrillation.
PMID: 26559559 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - November 12, 2015 Category: Hematology Authors: Potpara TS Tags: Thromb Haemost Source Type: research

Quality and predictors of anticoagulant control with vitamin K antagonist for stroke prevention in atrial fibrillation.
PMID: 27307147 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - June 15, 2016 Category: Hematology Authors: Wilson MR, Parakramawansha R, Quinn TJ, Tait RC Tags: Thromb Haemost Source Type: research

The role of atrial fibrillation in patients with an embolic stroke of unknown source (ESUS).
PMID: 28906543 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - September 14, 2017 Category: Hematology Authors: Wachter R, Freedman B Tags: Thromb Haemost Source Type: research

Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision.
Abstract PMID: 30458556 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - November 20, 2018 Category: Hematology Authors: Proietti M, Mujovic N, Potpara TS Tags: Thromb Haemost Source Type: research

Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights.
Abstract PMID: 30759487 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - February 13, 2019 Category: Hematology Authors: Borer JS, Atar D, Marciniak T, Kim MH, Serebruany V Tags: Thromb Haemost Source Type: research

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients.
Abstract The ARISTOTLE trial showed a risk reduction of stroke/systemic embolism (SE) and major bleeding in non-valvular atrial fibrillation (NVAF) patients treated with apixaban compared to warfarin. This retrospective study used four large US claims databases (MarketScan, PharMetrics, Optum, and Humana) of NVAF patients newly initiating apixaban or warfarin from January 1, 2013 to September 30, 2015. After 1:1 warfarin-apixaban propensity score matching (PSM) within each database, the resulting patient records were pooled. Kaplan-Meier curves and Cox proportional hazards models were used to estimate the cumulati...
Source: Thrombosis and Haemostasis - March 15, 2017 Category: Hematology Authors: Li X, Deitelzweig S, Keshishian A, Hamilton M, Horblyuk R, Gupta K, Luo X, Mardekian J, Friend K, Nadkarni A, Pan X, Lip GY Tags: Thromb Haemost Source Type: research

Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES.
CONCLUSION:  During the open-label extension, annual rates of stroke or systemic embolism, hemorrhagic stroke, and major bleeding remained as low as those observed during apixaban treatment in AVERROES. These data support the long-term efficacy and safety of apixaban in patients with atrial fibrillation. PMID: 33011964 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - October 3, 2020 Category: Hematology Authors: Benz AP, Eikelboom JW, Yusuf S, Hohnloser SH, Kahl A, Beresh H, Balasubramanian K, Healey JS, Connolly SJ Tags: Thromb Haemost Source Type: research

Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in nonvalvular atrial fibrillation patients: A multicenter propensity-matched analysis.
CONCLUSIONS: The heparin bridging therapy increased bleeding without the benefit of preventing stroke at the initiation of OAC in NVAF. Our data suggest that heparin bridging should not be considered at the initiation of OAC in NVAF patients. This article is protected by copyright. All rights reserved. PMID: 25472735 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - December 4, 2014 Category: Hematology Authors: Kim TH, Kim JY, Mun HS, Lee HY, Roh YH, Uhm JS, Pak HN, Lee MH, Joung B Tags: J Thromb Haemost Source Type: research

Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review.
CONCLUSION:  Interventions designed to improve appropriate prescription of OACs in eligible AF patients for stroke prevention can be effective. Successful approaches include education of HCPs; implementation of local guidelines; interdisciplinary medical care programs educating both HCPs and patients and persuasive interventions utilizing peer-group experts. Protocol registration: PROSPERO (CRD42016039654). PMID: 30669165 [PubMed - in process]
Source: Thrombosis and Haemostasis - January 24, 2019 Category: Hematology Authors: Pritchett RV, Bem D, Turner GM, Thomas GN, Clarke JL, Fellows R, Lane DA, Jolly K Tags: Thromb Haemost Source Type: research